DALLAS, Oct. 2, 2018 /PRNewswire/ — CardioVascular BioTherapeutics, Inc. (“CVBT” or the “Company”) is pleased to welcome Ori Ben-Yehuda, MD, FACC as our new Chief Medical Officer (CMO). “Dr. Ben-Yehuda brings leading edge skills and demonstrated drug development success to the Company. He will guide our clinical team in our current and future development […]